Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian L Abbott

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 28, 2006
ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cellsBrian L Abbott
Clinical Lymphoma & Myeloma|August 2, 2006
Diagnosis and management of lymphomaBrian L Abbott
Cancer Investigation|July 1, 2006
Recent advances in chronic lymphocytic leukemiaBrian L Abbott
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Advances in the diagnosis and treatment of chronic lymphocytic leukemiaBrian L Abbott
Hematological Oncology|October 28, 2003
ABCG2 (BCRP) expression in normal and malignant hematopoietic cellsBrian L Abbott
Clinical Therapeutics|January 31, 2012
Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemiaBrian L Abbott
The Oncologist|January 13, 2006
Chronic lymphocytic leukemia: recent advances in diagnosis and treatmentBrian L Abbott
Hematological Oncology|September 9, 2005
Advances in the diagnosis and treatment of chronic lymphocytic leukemiaBrian L Abbott
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunctionRobert Chen, Brian L Abbott, Han Myint
Blood|October 24, 2002
Low levels of ABCG2 expression in adult AML blast samplesBrian L Abbott, Anne-Marie Colapietro, Yuxiao Barnes, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Advances in Hematology & Oncology : H&O|March 28, 2006
ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cellsBrian L Abbott
Clinical Lymphoma & Myeloma|August 2, 2006
Diagnosis and management of lymphomaBrian L Abbott
Cancer Investigation|July 1, 2006
Recent advances in chronic lymphocytic leukemiaBrian L Abbott
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Advances in the diagnosis and treatment of chronic lymphocytic leukemiaBrian L Abbott
Hematological Oncology|October 28, 2003
ABCG2 (BCRP) expression in normal and malignant hematopoietic cellsBrian L Abbott
Clinical Therapeutics|January 31, 2012
Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemiaBrian L Abbott
The Oncologist|January 13, 2006
Chronic lymphocytic leukemia: recent advances in diagnosis and treatmentBrian L Abbott
Hematological Oncology|September 9, 2005
Advances in the diagnosis and treatment of chronic lymphocytic leukemiaBrian L Abbott
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunctionRobert Chen, Brian L Abbott, Han Myint
Blood|October 24, 2002
Low levels of ABCG2 expression in adult AML blast samplesBrian L Abbott, Anne-Marie Colapietro, Yuxiao Barnes, et al.
Pageof 2